Coming soon

Get notified when accounts open

Accounts are not open yet. Leave your email and we will tell you the moment sign-up is available.

Invesco's UroGen Pharma Ltd. (URGN) position

Yes: as of Q1 2026, Invesco holds 28K shares of URGN worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was increased by 3.7%. First disclosed Q3 2023.
View full portfolio →
Current value
an amount we cannot price
Shares held
28K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

URGN price vs Invesco's position

1Y 3Y 5Y MAX
Dates
← Earlier —10 purchases, 1 sell35404550
Average closing price · filing quarter
—
Price range · filing quarter
—
Get notified when accounts open

Every quarterly change

Every quarterly change
Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Added· Q1 2026 +1K
Quarter Q1 2026 Δ Own +3.7% Shares held 28K Filing date May 12, 2026
Q1 2026 Added· Q1 2026 +1K – +3.7% 28K May 12, 2026
Added· Q4 2025 +5K
Quarter Q4 2025 Δ Own +21.1% Shares held 27K Filing date Feb 19, 2026
Q4 2025 Added· Q4 2025 +5K – +21.1% 27K Feb 19, 2026
Added· Q3 2025 +10K
Quarter Q3 2025 Δ Own +75.5% Shares held 22K Filing date Nov 13, 2025
Q3 2025 Added· Q3 2025 +10K – +75.5% 22K Nov 13, 2025
Added· Q2 2025 +31
Quarter Q2 2025 Δ Own +0.2% Shares held 13K Filing date Aug 13, 2025
Q2 2025 Added· Q2 2025 +31 – +0.2% 13K Aug 13, 2025
Reduced· Q1 2025 −746
Quarter Q1 2025 Δ Own −5.5% Shares held 13K Filing date May 12, 2025
Q1 2025 Reduced· Q1 2025 −746 – −5.5% 13K May 12, 2025
Added· Q4 2024 +634
Quarter Q4 2024 Δ Own +4.9% Shares held 13K Filing date Feb 13, 2025
Q4 2024 Added· Q4 2024 +634 – +4.9% 13K Feb 13, 2025
Added· Q3 2024 +1K
Quarter Q3 2024 Δ Own +9.9% Shares held 13K Filing date Nov 12, 2024
Q3 2024 Added· Q3 2024 +1K – +9.9% 13K Nov 12, 2024
Added· Q2 2024 +905
Quarter Q2 2024 Δ Own +8.4% Shares held 12K Filing date Aug 13, 2024
Q2 2024 Added· Q2 2024 +905 – +8.4% 12K Aug 13, 2024
Added· Q1 2024 +656
Quarter Q1 2024 Δ Own +6.5% Shares held 11K Filing date May 14, 2024
Q1 2024 Added· Q1 2024 +656 – +6.5% 11K May 14, 2024
Added· Q4 2023 +47
Quarter Q4 2023 Δ Own +0.5% Shares held 10K Filing date Feb 13, 2024
Q4 2023 Added· Q4 2023 +47 – +0.5% 10K Feb 13, 2024
New· Q3 2023 +10K
Quarter Q3 2023 Shares held 10K Filing date Nov 13, 2023
Q3 2023 New· Q3 2023 +10K – – 10K Nov 13, 2023
Data through Q1 2026 · filed May 12, 2026
11 of 11

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own URGN?

Yes. As of Q1 2026, Invesco disclosed 28K shares of URGN, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy URGN?

Invesco first disclosed a URGN position in Q3 2023; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell URGN?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in URGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of URGN does Invesco own?

Invesco disclosed 28K shares of URGN as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for URGN?

Invesco began building the URGN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.